PDXK ‐Related Neuropathy: A Case With a Novel Splice‐Altering Missense Variant and Literature Review

Read full text Summarise with VIRAT
Authors: Dmitrii Subbotin, Daria Akimova, Дадали Елена Леонидовна, Kristina A. Mikhalchuk, Artem O. Borovikov, В. В. Кадышев, Mikhail Y. Skoblov, Aysylu F. Murtazina
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: PDXK-related neuropathy is a rare form of hereditary motor and sensory neuropathy with optic atrophy, caused by biallelic variants in the PDXK gene. To date, only four missense variants have been reported in 13 patients from six families. Unlike most inherited neuropathies, which currently have only symptomatic treatments, this type of neuropathy can be managed with pyridoxal 5'-phosphate supplementation. METHODS: The clinical presentation of the patient was evaluated twice, at ages 14 and 15 years. The whole-exome sequencing was performed for the proband followed by functional studies using RNA extracted from the proband's and proband's mother's peripheral blood mononuclear cells. RESULTS: In this study, we provided a brief literature review on PDXK-related neuropathy and reported a female patient with a novel missense variant (c.826G>C, p.(Ala276Pro)) found in compound heterozygous state with a previously reported variant (c.659G>A, p.[Arg220Gln]) in the PDXK gene. Additionally, she carried a novel likely pathogenic missense variant (c.1180C>T, p.[Arg394Cys]) in the GCK gene, associated with MODY2, which was segregated with hyperglycemia in her family. The novel variant c.826G>C in the PDXK gene was predicted to disrupt splicing that was confirmed by our functional studies. The patient exhibited typical peripheral neuropathy but no optic atrophy, likely due to her young age. CONCLUSIONS: Here we report a novel splice-altering missense variant in PDXK that induces aberrant transcript degradation, revealing a new disease mechanism for PDXK-related neuropathy.

Fields of Study & Subjects

Hereditary Neurological Disorders Metabolism and Genetic Disorders Genomics and Rare Diseases

Publication details

Journal / source
Molecular Genetics & Genomic Medicine
Volume
14
Issue
4
Pages
e70210–e70210
Publication date
26 March 2026
Language
EN